Results 211 to 220 of about 2,636,320 (328)

Deciphering the skeletal interoceptive circuitry to control bone homeostasis

open access: yesBMEMat, EarlyView.
This review introduces the skeletal interoceptive circuitry, covering the ascending signals from bone tissues to the brain (sensors), the central neural circuits that integrate this information and dispatch commands (CPU), and the descending pathways that regulate bone homeostasis (effectors).
Yefeng Wu   +7 more
wiley   +1 more source

A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling

open access: yesScience, 2005
C. Revankar   +4 more
semanticscholar   +1 more source

Innovative transdermal drug delivery systems: Benefits, challenges, and emerging application

open access: yesBMEMat, EarlyView.
The graphical abstract illustrates the diverse nanostructures employed in transdermal drug delivery systems, highlighting their unique mechanisms to penetrate the intricate layers of skin. It provides a detailed representation of the skin's complex anatomy, emphasizing the challenges posed by its barrier properties.
Syed Waqas Ali Shah   +9 more
wiley   +1 more source

Gut microbiota has the potential to improve health of menopausal women by regulating estrogen. [PDF]

open access: yesFront Endocrinol (Lausanne)
Wang H   +6 more
europepmc   +1 more source

Endothelium and estrogen receptors

open access: yesBiomedicine & Pharmacotherapy, 2006
SIMONCINI, TOMMASO   +10 more
openaire   +3 more sources

Sex-Specific Differences in LPS-Induced Rapid Myocardial Dysfunction. [PDF]

open access: yesInt J Mol Sci
Harvey BI   +6 more
europepmc   +1 more source

Estrogen receptors and human disease: an update

open access: yesArchives of Toxicology, 2012
K. A. Burns, K. Korach
semanticscholar   +1 more source

Adjuvant capecitabine in combination with docetaxel and cyclophosphamide versus anthracycline plus docetaxel and cyclophosphamide regimen in women with high‐risk, HER2‐negative breast cancer: An open‐label, randomized controlled trial

open access: yesCancer Communications, EarlyView.
Abstract Background The standard adjuvant chemotherapy for early‐stage, high‐risk breast cancer includes anthracyclines and taxanes. While anthracycline‐based regimens have proven effective in human epidermal growth factor receptor 2 (HER2)‐positive breast cancer, their efficacy may be reduced in HER2‐negative patients due to the lack of co ...
Yu Song   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy